KRISTEN KALKA: Open Payments
NPI 1215565346 · NORTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 42 payments from 14 companies in 2025. Trend: 2023 $1,159 · 2024 $1,574 · 2025 $760
Food & beverage: $676Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $268 |
| Janssen Biotech, Inc. | 3 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| Ipsen Biopharmaceuticals, Inc | 3 | $57 |
| QOL Medical, LLC | 2 | $43 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $32 |
| Biocon Biologics Inc | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Celltrion USA Inc. | 1 | $21 |
Products named: RINVOQ, TREMFYA, ENTYVIO, VIBERZI, Sucraid, REZDIFFRA, IQIRVO, LINZESS.
Industry payments across OH — which companies pay providers there.
